2-[1h-benzimidazol-2(3h)-ilideno]-2-(pirimidin-2-il) acetamidas e 2-[benzotiazol-2(3h)-ilideno]-2-il) acetamidas como inibidores de quinase

2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and their salts are kinase inhibitors, useful in the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors TRUONG VU, REYNA J. SIMON, NATALIA AURECOECHEA, KAREN Y. PONTIUS, KOMATH V. DAMODARAN, LOUISE ROBINSON, KEVIN T. WEBER, PAUL P. BEROZA
Format Patent
LanguagePortuguese
Published 01.12.2015
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and their salts are kinase inhibitors, useful in the treatment of cancer.
Bibliography:Application Number: BR2009PI18509